The biological vaccine sector weakened, and Watson biology fell more than 6%
The biological vaccine sector weakened. As of press time, Watson biology fell by more than 6%, Zhifei biology and Boya biology fell by more than 5%, Changchun hi tech fell by more than 4%, and Wantai biology, kangxinuo and dongfulong followed suit.
This text is a result of machine translation.
Related companies：
Briefing Jan 21, 2022 12:19 PM
· Technology
Changchun hi tech: nine directors, supervisors and senior management personnel increased their holdings of 84700 shares in the company
In depth
Briefing Jan 20, 2022 02:49 PM
· Technology
Consumer electronics stocks continued to decline
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Apr 22, 2021 03:11 PM
Jan 28, 2021 01:11 PM
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
Financials · Analysis
Beijing Stock Exchange: A New Playground for China's Rapidly Growing SMEs
Beijing is fostering its 'little giants.'
Jan 11, 2022 04:53 PM
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
See more
Read next
Insight
Technology
Another Look at China's Semiconductor Manufacturing Equipment Industry
Jan 19, 2022 02:58 PM
Insight
In depth
Automotive
Carnex: A Growing Life Cycle Used EV Platform Founded by Tesla Enthusiasts
Jan 19, 2022 07:59 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.